AU2002357972A1 - Heparin-containing ophthalmic agent - Google Patents

Heparin-containing ophthalmic agent

Info

Publication number
AU2002357972A1
AU2002357972A1 AU2002357972A AU2002357972A AU2002357972A1 AU 2002357972 A1 AU2002357972 A1 AU 2002357972A1 AU 2002357972 A AU2002357972 A AU 2002357972A AU 2002357972 A AU2002357972 A AU 2002357972A AU 2002357972 A1 AU2002357972 A1 AU 2002357972A1
Authority
AU
Australia
Prior art keywords
heparin
ophthalmic agent
containing ophthalmic
agent
mucopolysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002357972A
Other languages
English (en)
Inventor
Dorothea Gross
Frank Holzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ursapharm Arzneimittel GmbH
Original Assignee
Ursapharm Arzneimittel GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ursapharm Arzneimittel GmbH filed Critical Ursapharm Arzneimittel GmbH
Publication of AU2002357972A1 publication Critical patent/AU2002357972A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AU2002357972A 2001-12-12 2002-12-11 Heparin-containing ophthalmic agent Abandoned AU2002357972A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10161149A DE10161149B4 (de) 2001-12-12 2001-12-12 Verwendung von Heparin-haltigem Ophthalmikum
DE10161149.8 2001-12-12
PCT/DE2002/004526 WO2003053452A1 (de) 2001-12-12 2002-12-11 Heparin-haltiges ophthalmikum

Publications (1)

Publication Number Publication Date
AU2002357972A1 true AU2002357972A1 (en) 2003-07-09

Family

ID=7709005

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002357972A Abandoned AU2002357972A1 (en) 2001-12-12 2002-12-11 Heparin-containing ophthalmic agent

Country Status (11)

Country Link
US (1) US20050043271A1 (https=)
EP (1) EP1453523B1 (https=)
JP (1) JP2005513106A (https=)
CN (1) CN1604784A (https=)
AT (1) ATE318607T1 (https=)
AU (1) AU2002357972A1 (https=)
CA (1) CA2468775A1 (https=)
DE (2) DE10161149B4 (https=)
ES (1) ES2259727T3 (https=)
MX (1) MXPA04005390A (https=)
WO (1) WO2003053452A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1279406A4 (en) * 2000-04-03 2007-10-24 Santen Pharmaceutical Co Ltd TRANSPORTERS AND DRUG DISPENSING SYSTEMS USING THESE
WO2004093878A1 (en) * 2003-04-16 2004-11-04 Alcon, Inc. Use of fused pyridazine derivatives for treating dry eye disorders
DE10360425A1 (de) * 2003-12-19 2005-07-28 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Hyaluronsäure, Hyaluronat und/oder deren Derivate zur Herstellung einer pharmazeutischen Zusammensetzung
JP2005187407A (ja) * 2003-12-25 2005-07-14 Lion Corp アレルギー眼疾患用眼科組成物
DE102004002001A1 (de) * 2004-01-14 2005-08-11 Reinmüller, Johannes, Dr.med. Mittel zur Behandlung von entzündlichen Erkrankungen
DE102005035986B4 (de) * 2005-07-28 2009-10-15 Bausch & Lomb Incorporated Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat
DE102005055275A1 (de) * 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
DE102006049091A1 (de) * 2006-10-18 2008-04-24 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Emulgatorfreies ophthalmisches Präparat enthaltend Pflanzenöl
FR2919185B1 (fr) * 2007-07-23 2010-09-10 Ard Sa Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses
SI2679278T1 (en) * 2008-11-20 2018-02-28 Laboratori Derivati Organici S.P.A. Dermatological compositions comprising heparan sulphate
WO2010144874A2 (en) 2009-06-12 2010-12-16 University Of Southern California Clusterin pharmaceuticals and treatment methods using the same
FR2962044B1 (fr) * 2010-04-21 2013-02-22 Horus Pharma Emulsion lacrymimetique
JP2016185940A (ja) * 2014-06-10 2016-10-27 ロート製薬株式会社 眼科用組成物
DE102016203696A1 (de) 2016-03-07 2017-09-07 Ursapharm Arzneimittel Gmbh Ophthalmologische Zusammensetzung
US20190240251A1 (en) * 2016-10-14 2019-08-08 i.com medical GmbH Method for establishing, restoring, and preserving homeostasis of the ocular surface
JP2020525416A (ja) * 2017-06-29 2020-08-27 アドヴァイテ エルエルシー． 眼表面障害の治療及び診断
TWI698241B (zh) * 2017-09-05 2020-07-11 國立成功大學 用於治療缺血的肝素組合物
EP3740191B1 (en) * 2018-01-18 2021-04-28 Faes Farma, S.A. Ophthalmic compositions comprising bilastine, a beta-cyclodextrin and at least one gelling agent
CN112292135A (zh) 2018-04-18 2021-01-29 I.Com医疗有限责任公司 用于治疗和预防严重眼表疾病的高分子量透明质酸
US12268706B2 (en) 2019-01-31 2025-04-08 i.com medical GmbH Hyaluronic acid for relief of idiopathic ocular pain
CN116139067B (zh) * 2021-11-22 2024-03-22 华熙生物科技股份有限公司 透明质酸锌形成凝胶的方法及含有透明质酸锌的滴眼凝胶及其制备
TW202404617A (zh) * 2022-07-29 2024-02-01 日商瑪路弘股份有限公司 眼科用組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1730M (fr) * 1962-01-17 1963-03-18 Charles Riviere Nouvelle composition de collyre.
DE3440352A1 (de) * 1984-11-05 1986-05-07 Dr. Thilo & Co GmbH, 8029 Sauerlach Dry-eye-packung
DE3787188T2 (de) * 1986-04-04 1993-12-16 Allergan Inc Zähflüssiges Präparat zur Anwendung bei Wunden in der Augenhornhaut.
JPS6479103A (en) * 1987-06-09 1989-03-24 Lion Corp External preparation
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
JPH02167233A (ja) * 1988-11-10 1990-06-27 Kiyoshi Kita 眼内手術補助剤
US5141741A (en) * 1988-12-09 1992-08-25 Lion Corporation Anti-sunburn skin-care preparation
US5358706A (en) * 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
IT1273011B (it) * 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
DE19520575A1 (de) * 1995-06-06 1996-12-12 Permselect Ges Fuer Zellstrukt Hautwirksame Kombination von Mucopolysacchariden
DE19547972A1 (de) * 1995-12-21 1997-07-10 Weropharm Gmbh Heparin zur Prophylaxe und akuten Therapie der allergischen Konjunktivitis
KR100514963B1 (ko) * 1997-07-11 2005-09-15 도레이 가부시끼가이샤 4,5-에폭시모르피난 유도체를 함유하는 안정한 의약품 조성물
US6348508B1 (en) * 2000-04-04 2002-02-19 Bausch & Lomb Incorporated Method for treating dry eye

Also Published As

Publication number Publication date
CA2468775A1 (en) 2003-07-03
CN1604784A (zh) 2005-04-06
DE50205968D1 (de) 2006-04-27
ATE318607T1 (de) 2006-03-15
MXPA04005390A (es) 2005-10-18
EP1453523A1 (de) 2004-09-08
JP2005513106A (ja) 2005-05-12
US20050043271A1 (en) 2005-02-24
DE10161149B4 (de) 2007-03-08
DE10161149A1 (de) 2003-06-26
WO2003053452A1 (de) 2003-07-03
EP1453523B1 (de) 2006-03-01
ES2259727T3 (es) 2006-10-16

Similar Documents

Publication Publication Date Title
AU2002357972A1 (en) Heparin-containing ophthalmic agent
WO2002100437A3 (en) Ophthalmic compositions comprising hyaluronic acid
WO2004028571A3 (en) Implantable stent with modified ends
DK0781547T3 (da) Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi
WO2004091446A3 (en) Medical device delivery systems
WO2004017861A3 (en) Implantable replacement joint
WO1996040055A3 (en) Biological agent compositions
AU2003245325A1 (en) Substituted quinazolinone compounds
WO2000006133A3 (en) Compositions for treating diseases associated with glycosaminoglycan-associated molecular interactions
AU2001234504A1 (en) Methods, systems, and presentations for delivery over the internet
DK1589088T3 (da) Ny bioklæbende sammensætning, som omfatter et bioklæbende polyphenolisk protein, en polymer, der omfatter kulhydratgrupper, og farmaceutisk acceptable tynde filamenter, samt anvendelser deraf
BRPI0407583A (pt) solução oftálmica lìmpida e estável
EP2431385A3 (en) Combination therapy with chlorotoxin
AU2002300735A1 (en) Agent desktop management system with agent training
FR2805465B1 (fr) Nouvelles compositions pharmaceutique ou dietetiques a base de champignons
AU7961900A (en) Skin texture-improving agents
WO2003104576A3 (en) Structure having preinstalled utilities and amenities
WO2002096367A3 (en) Targeted multivalent macromolecules
MY122877A (en) Composition.
WO2003082926A3 (en) Antimicrobial polymer conjugates
AU7918500A (en) Substituted diazepanes
WO2003084499A3 (de) Gelförmige reinigungszubereitungen vorgelatinisierte, quervernetzte stärkederivate und polyacrylate enthaltend
WO2005032483A3 (en) Polysaccharides for pulmonary delivery of active agents
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
AU1932997A (en) Dosage forms and uses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase